pain

Thumbs-down from FDA experts for Pfizer/Lilly’s painkiller tanezumab

https://pharmaphorum.com/news/fda-experts-give-thumbs-down-for-pfizer-lillys-painkiller-tanezumab/

FDA worried about Pfizer/Lilly pain drug safety ahead of key meeting

https://pharmaphorum.com/news/fda-worried-pfizer-lilly-pain-drug-safety-ahead-of-key-meeting/

Kaia Health creates new ‘front door’ for MSK pain services

https://pharmaphorum.com/news/kaia-health-creates-new-front-door-for-msk-pain-services/

Lilly adds to pain pipeline with Asahi Kasei licensing deal

https://pharmaphorum.com/news/lilly-adds-to-pain-pipeline-with-asahi-kasei-licensing-deal/

Satsuma pulped as acute migraine drug flunks phase 3 trial

https://pharmaphorum.com/news/satsuma-pulped-as-acute-migraine-drug-flunks-phase-3-trial/

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

https://pharmaphorum.com/news/fda-starts-review-of-pfizer-lillys-non-opioid-painkiller/

Exclusive Speaker Interview with Stephen Hunt, Professor, UCL, ahead of Pain Therapeutics

https://pharmaphorum.com/partner-content/exclusive-speaker-interview-with-stephen-hunt-professor-ucl-ahead-of-pain-therapeutics/

Durect’s post-op painkiller splits FDA advisory panel

https://pharmaphorum.com/news/durects-post-op-painkiller-splits-fda-advisory-panel/

Nektar pulls pain drug after bruising FDA panel meeting

https://pharmaphorum.com/news/nektar-pulls-pain-drug-after-bruising-fda-panel-meeting/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search